Följ
Lucas Matías Opazo Ríos
Lucas Matías Opazo Ríos
Académico Investigador, Escuela de Kinesiología, Universidad de las Américas, Concepción, Chile
Verifierad e-postadress på udla.cl
Titel
Citeras av
Citeras av
År
Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities
L Opazo-Ríos, S Mas, G Marín-Royo, S Mezzano, C Gómez-Guerrero, ...
International journal of molecular sciences 21 (7), 2632, 2020
1912020
Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy
S Rayego-Mateos, JL Morgado-Pascual, L Opazo-Ríos, M Guerrero-Hue, ...
International journal of molecular sciences 21 (11), 3798, 2020
1832020
Targeting inflammation in diabetic nephropathy: a tale of hope
JA Moreno, C Gomez-Guerrero, S Mas, AB Sanz, O Lorenzo, ...
Expert opinion on investigational drugs 27 (11), 917-930, 2018
1602018
The coming age of flavonoids in the treatment of diabetic complications
T Caro-Ordieres, G Marín-Royo, L Opazo-Ríos, L Jiménez-Castilla, ...
Journal of clinical medicine 9 (2), 346, 2020
812020
Protective role of Nrf2 in renal disease
M Guerrero-Hue, S Rayego-Mateos, C Vázquez-Carballo, ...
Antioxidants 10 (1), 39, 2020
602020
Toll-like receptors in acute kidney injury
C Vázquez-Carballo, M Guerrero-Hue, C García-Caballero, ...
International journal of molecular sciences 22 (2), 816, 2021
532021
Could IL-17A be a novel therapeutic target in diabetic nephropathy?
C Lavoz, S Rayego-Mateos, M Orejudo, L Opazo-Ríos, V Marchant, ...
Journal of clinical medicine 9 (1), 272, 2020
392020
Butyric acid stimulates bovine neutrophil functions and potentiates the effect of platelet activating factor
MD Carretta, AI Hidalgo, J Burgos, L Opazo, L Castro, MA Hidalgo, ...
Veterinary Immunology and Immunopathology 176, 18-27, 2016
282016
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes
L Opazo-Ríos, YS Matus, RR Rodrigues-Díez, D Carpio, A Droguett, ...
BMJ Open Diabetes Research and Care 8 (1), e001242, 2020
162020
Meta-inflammation and De novo lipogenesis markers are involved in metabolic associated fatty liver disease progression in BTBR Ob/Ob mice
L Opazo-Ríos, M Soto-Catalán, I Lázaro, A Sala-Vila, L Jiménez-Castilla, ...
International Journal of Molecular Sciences 23 (7), 3965, 2022
102022
Targeting NF-κB by the cell-permeable NEMO-binding domain peptide improves albuminuria and renal lesions in an experimental model of type 2 diabetic nephropathy
L Opazo-Ríos, A Plaza, Y Sánchez Matus, S Bernal, L Lopez-Sanz, ...
International Journal of Molecular Sciences 21 (12), 4225, 2020
102020
Kidney microRNA expression pattern in type 2 diabetic nephropathy in BTBR Ob/Ob mice
L Opazo-Ríos, A Tejera-Muñoz, M Soto Catalan, V Marchant, C Lavoz, ...
Frontiers in Pharmacology 13, 778776, 2022
82022
Nephroprotective effects of synthetic flavonoid hidrosmin in experimental diabetic nephropathy
L Jiménez-Castilla, G Marín-Royo, M Orejudo, L Opazo-Ríos, ...
Antioxidants 10 (12), 1920, 2021
62021
Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury
C Vázquez‐Carballo, C Herencia, M Guerrero‐Hue, C García‐Caballero, ...
The Journal of pathology 258 (3), 236-249, 2022
22022
The synthetic flavonoid hidrosmin improves endothelial dysfunction and atherosclerotic lesions in diabetic mice
L Jiménez-Castilla, L Opazo-Ríos, G Marin-Royo, M Orejudo, ...
Antioxidants 11 (12), 2499, 2022
12022
Recommendations for implementation of physical training guidelines for patients undergoing chronic hemodialysis
H Müller-Ortiz, P Moscoso-Aguayo, J Troncoso-Riquelme, ...
Universidad de Alicante. Área de Educación Física y Deporte, 2021
12021
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease
M Soto-Catalán, L Opazo-Ríos, H Quiceno, I Lázaro, JA Moreno, ...
International Journal of Molecular Sciences 25 (5), 2961, 2024
2024
Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade
S Rayego‐Mateos, JL Morgado‐Pascual, C García‐Caballero, I Lazaro, ...
The Journal of Pathology 261 (2), 169-183, 2023
2023
P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE
L Opazo-Rios, M Soto-Catalan, I Lázaro, A Sala-Vila, C Pérez-Gallardo, ...
Annals of Hepatology 28, 100906, 2023
2023
FC 037 NEUTROPHILS PLAY A KEY ROLE IN THE INITIATION OF GLOMERULAR HEMATURIA IN A POSTINFECTIOUS IGAN EXPERIMENTAL MODEL
C Herencia, M Guerrero Hue, C Vazquez-Carballo, C De Tymowski, ...
Nephrology Dialysis Transplantation 36 (Supplement_1), gfab117. 001, 2021
2021
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20